A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats

Biological Psychiatry

Volumn 73, Issue 8, 2013, Pages 721-728

  Miller, Michelle L ^a   Moreno, Amira Y ^a   Aarde, Shawn M ^a   Creehan, Kevin M ^a   Vandewater, Sophia A ^a   Vaillancourt, Brittani D ^a   Wright Jr , M Jerry ^a   Janda, Kim D ^a   Taffe, Michael A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Activity; d methamphetamine; drug addiction; immunopharmacotherapy; stimulants; thermoregulation

Indexed keywords

ANTI METHAMPHETAMINE VACCINE; KEYHOLE LIMPET HEMOCYANIN; METHAMPHETAMINE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFICACY; ENVIRONMENTAL TEMPERATURE; IN VIVO STUDY; LOCOMOTION; MALE; METHAMPHETAMINE DEPENDENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RAT; RECTUM TEMPERATURE; TELEMETRY; THERMOREGULATION;

ANIMALS; ANTIBODIES; BODY TEMPERATURE REGULATION; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; RATS; VACCINES;

EID: 84875746967     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.09.010     Document Type: Article

References (60)

1. B. Kuehn FDA warns of adverse events linked to smoking cessation drug and antiepileptics JAMA 10 2008 1121 1122
2. A.Y. Moreno, and K.D. Janda Immunopharmacotherapy: Vaccination strategies as a treatment for drug abuse and dependence Pharmacol Biochem Behav 92 2009 199 205
3. X. Shen, and T.R. Kosten Immunotherapy for drug abuse CNS Neurol Disord Drug Targets 10 2011 876 879
4. M.G. LeSage, D.E. Keyler, and P.R. Pentel Current status of immunologic approaches to treating tobacco dependence: Vaccines and nicotine-specific antibodies AAPS J 8 2006 E65 E75
5. W.B. Gentry, D. Ruedi-Bettschen, and S.M. Owens Development of active and passive human vaccines to treat methamphetamine addiction Hum Vaccin 5 2009 206 213
6. K.D. Janda, and J.B. Treweek Vaccines targeting drugs of abuse: Is the glass half-empty or half-full? Nat Rev Immunol 12 2012 67 72
7. K.M. Kantak, S.L. Collins, J. Bond, and B.S. Fox Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010 Psychopharmacology (Berl) 153 2001 334 340
8. K.M. Kantak, S.L. Collins, E.G. Lipman, J. Bond, K. Giovanoni, and B.S. Fox Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model Psychopharmacology (Berl) 148 2000 251 262
9. S. Wee, M.J. Hicks, B.P. De, J.B. Rosenberg, A.Y. Moreno, and S.M. Kaminsky Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects Neuropsychopharmacology 37 2012 1083 1091
10. M.R. Carrera, J.A. Ashley, L.H. Parsons, P. Wirsching, G.F. Koob, and K.D. Janda Suppression of psychoactive effects of cocaine by active immunization Nature 378 1995 727 730
11. M.R. Carrera, J.A. Ashley, P. Wirsching, G.F. Koob, and K.D. Janda A second-generation vaccine protects against the psychoactive effects of cocaine Proc Natl Acad Sci U S A 98 2001 1988 1992
12. M.R. Carrera, J.A. Ashley, B. Zhou, P. Wirsching, G.F. Koob, and K.D. Janda Cocaine vaccines: Antibody protection against relapse in a rat model Proc Natl Acad Sci U S A 97 2000 6202 6206
13. M.R. Carrera, J.A. Ashley, T.Z. Hoffman, S. Isomura, P. Wirsching, G.F. Koob, and K.D. Janda Investigations using immunization to attenuate the psychoactive effects of nicotine Bioorg Med Chem 12 2004 563 570
14. M.G. LeSage, D.E. Keyler, Y. Hieda, G. Collins, D. Burroughs, C. Le, and P.R. Pentel Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats Psychopharmacology (Berl) 184 2006 409 416
15. N. Lindblom, S.H. de Villiers, G. Kalayanov, S. Gordon, A.M. Johansson, and T.H. Svensson Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats Respiration 69 2002 254 260
16. S.A. Roiko, A.C. Harris, D.E. Keyler, M.G. Lesage, Y. Zhang, and P.R. Pentel Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats J Pharmacol Exp Ther 325 2008 985 993
17. P.R. Pentel, D.H. Malin, S. Ennifar, Y. Hieda, D.E. Keyler, and J.R. Lake A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats Pharmacol Biochem Behav 65 2000 191 198
18. E.H. Cerny, R. Levy, J. Mauel, M. Mpandi, M. Mutter, and C. Henzelin-Nkubana Preclinical development of a vaccine 'against smoking' Onkologie 25 2002 406 411
19. S.H. de Villiers, N. Lindblom, G. Kalayanov, S. Gordon, A.M. Johansson, and T.H. Svensson Active immunization against nicotine alters the distribution of nicotine but not the metabolism to cotinine in the rat Naunyn Schmiedebergs Arch Pharmacol 370 2004 299 304
20. D.E. Keyler, Y. Hieda St, J. Peter, and P.R. Pentel Altered disposition of repeated nicotine doses in rats immunized against nicotine Nicotine Tob Res 1 1999 241 249
21. D.E. Keyler, S.A. Roiko, E. Benlhabib, M.G. LeSage St, J.V. Peter, and S. Stewart Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: Dose- and affinity-response relationships Drug Metab Dispos 33 2005 1056 1061
22. B. Berkowitz, and S. Spector Evidence for active immunity to morphine in mice Science 178 1972 1290 1292
23. K.F. Bonese, B.H. Wainer, F.W. Fitch, R.M. Rothberg, and C.R. Schuster Changes in heroin self-administration by a rhesus monkey after morphine immunisation Nature 252 1974 708 710
24. M. Strahilevitz, K.A. Kelly, P.T. Tsui, and A.H. Sehon Blocking of the effect of delta1 tetrahydrocannabinol (delta1THC) on spontaneous motor activity in the rat by immunization with a protein conjugate of delta1THC Life Sci 14 1974 1975 1989
25. J.L. Valentine, and S.M. Owens Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats J Pharmacol Exp Ther 278 1996 717 724
26. J.S. Hardin, W.D. Wessinger, G.R. Wenger, J.W. Proksch, E.M. Laurenzana, and S.M. Owens A single dose of monoclonal anti-phencyclidine IgG offers long-term reductions in phencyclidine behavioral effects in rats J Pharmacol Exp Ther 302 2002 119 126
27. T.R. Kosten, M. Rosen, J. Bond, M. Settles, J.S. Roberts, and J. Shields Human therapeutic cocaine vaccine: Safety and immunogenicity Vaccine 20 2002 1196 1204
28. M. Haney, E.W. Gunderson, H. Jiang, E.D. Collins, and R.W. Foltin Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans Biol Psychiatry 67 2010 59 65
29. B.A. Martell, F.M. Orson, J. Poling, E. Mitchell, R.D. Rossen, T. Gardner, and T.R. Kosten Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: A randomized, double-blind, placebo-controlled efficacy trial Arch Gen Psychiatry 66 2009 1116 1123
30. J. Cornuz, S. Zwahlen, W.F. Jungi, J. Osterwalder, K. Klingler, and G. van Melle A vaccine against nicotine for smoking cessation: A randomized controlled trial PLoS One 3 2008 e2547
31. D.K. Hatsukami, D.E. Jorenby, D. Gonzales, N.A. Rigotti, E.D. Glover, and C.A. Oncken Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic Clin Pharmacol Ther 89 2011 392 399
32. D.E. McMillan, W.C. Hardwick, M. Li, M.G. Gunnell, F.I. Carroll, P. Abraham, and S.M. Owens Effects of murine-derived anti-methamphetamine monoclonal antibodies on (+)-methamphetamine self-administration in the rat J Pharmacol Exp Ther 309 2004 1248 1255
33. K.A. Byrnes-Blake, E.M. Laurenzana, F.I. Carroll, P. Abraham, W.B. Gentry, R.D. Landes, and S.M. Owens Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats Eur J Pharmacol 461 2003 119 128
34. K.A. Byrnes-Blake, E.M. Laurenzana, R.D. Landes, W.B. Gentry, and S.M. Owens Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats Eur J Pharmacol 521 2005 86 94
35. W.B. Gentry, E.M. Laurenzana, D.K. Williams, J.R. West, R.J. Berg, T. Terlea, and S.M. Owens Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats Int Immunopharmacol 6 2006 968 977
36. D.E. McMillan, W.C. Hardwick, M. Li, and S.M. Owens Pharmacokinetic antagonism of (+)-methamphetamine discrimination by a low-affinity monoclonal anti-methamphetamine antibody Behav Pharmacol 13 2002 465 473
37. K.A. Byrnes-Blake, F.I. Carroll, P. Abraham, and S.M. Owens Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats Int Immunopharmacol 1 2001 329 338
38. M.J. Duryee, R.A. Bevins, C.M. Reichel, J.E. Murray, Y. Dong, G.M. Thiele, and S.D. Sanderson Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines Vaccine 27 2009 2981 2988
39. F.I. Carroll, B.E. Blough, R.R. Pidaparthi, P. Abraham, P.K. Gong, and L. Deng Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines J Med Chem 54 2011 5221 5228
40. A.Y. Moreno, A.V. Mayorov, and K.D. Janda Impact of distinct chemical structures for the development of a methamphetamine vaccine J Am Chem Soc 133 2011 6587 6595
41. N.W. Gilpin, M.J. Wright Jr, G. Dickinson, S.A. Vandewater, J.U. Price, and M.A. Taffe Influences of activity wheel access on the body temperature response to MDMA and methamphetamine Pharmacol Biochem Behav 99 2011 295 300
42. Huang PK, Aarde SM, Angrish D, Houseknecht KL, Dickerson TJ, Taffe MA (2012): Contrasting effects of d-methamphetamine, 3,4- methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats [published online ahead of print June 2]. Drug Alcohol Depend http://dx.doi.org/10.1016/j.drugalcdep.2012.05.011
43. Miller ML, Creehan KM, Angrish D, Barlow DJ, Houseknecht KL, Dickerson TJ, Taffe MA (2012): Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone) [published online ahead of print July 23]. Drug Alcohol Depend http://dx.doi.org/10.1016/j.drugalcdep.2012.07.003
44. H. Hendrickson, E. Laurenzana, and S.M. Owens Quantitative determination of total methamphetamine and active metabolites in rat tissue by liquid chromatography with tandem mass spectrometric detection AAPS J 8 2006 E709 E717
45. E.M. Laurenzana, K.A. Byrnes-Blake, A. Milesi-Halle, W.B. Gentry, D.K. Williams, and S.M. Owens Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in rats Drug Metab Dispos 31 2003 1320 1326
46. M.J. Hicks, B.P. De, J.B. Rosenberg, J.T. Davidson, A.Y. Moreno, and K.D. Janda Cocaine analog coupled to disrupted adenovirus: A vaccine strategy to evoke high-titer immunity against addictive drugs Mol Ther 19 2011 612 619
47. M. Pravetoni, D.E. Keyler, M.D. Raleigh, A.C. Harris, M.G. Lesage, and C.K. Mattson Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats Biochem Pharmacol 81 2011 1164 1170
48. E.M. Laurenzana, H.P. Hendrickson, D. Carpenter, E.C. Peterson, W.B. Gentry, and M. West Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats Vaccine 27 2009 7011 7020
49. J.C. Buffum, and A.T. Shulgin Overdose of 2.3 grams of intravenous methamphetamine: Case, analysis and patient perspective J Psychoactive Drugs 33 2001 409 412
50. M.E. Wallace, and R. Squires Fatal massive amphetamine ingestion associated with hyperpyrexia J Am Board Fam Pract 13 2000 302 304
51. S.R. White Amphetamine toxicity Semin Respir Crit Care Med 23 2002 27 36
52. B.J. Myles, L.A. Jarrett, S.L. Broom, H.A. Speaker, and K.E. Sabol The effects of methamphetamine on core body temperature in the rat - part 1: Chronic treatment and ambient temperature Psychopharmacology (Berl) 198 2008 301 311
53. P.M. Groves, and R.F. Thompson Habituation: A dual-process theory Psychol Rev 77 1970 419 450
54. V. Della Maggiore, and M.R. Ralph The effect of amphetamine on locomotion depends on the motor device utilized. The open field vs. the running wheel Pharmacol Biochem Behav 65 2000 585 590
55. A.J. Bradbury, B. Costall, R.J. Naylor, and E.S. Onaivi 5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse Psychopharmacology (Berl) 93 1987 457 465
56. W.B. Gentry, A.U. Ghafoor, W.D. Wessinger, E.M. Laurenzana, H.P. Hendrickson, and S.M. Owens (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration Pharmacol Biochem Behav 79 2004 751 760
57. N.M. Petry, S.M. Alessi, and D.M. Ledgerwood A randomized trial of contingency management delivered by community therapists J Consult Clin Psychol 80 2012 286 298
58. S.T. Higgins, A.J. Budney, W.K. Bickel, F.E. Foerg, R. Donham, and G.J. Badger Incentives improve outcome in outpatient behavioral treatment of cocaine dependence Arch Gen Psychiatry 51 1994 568 576
59. J. Dallery, and B. Raiff Monetary-based consequences for drug abstinence: Methods of implementation and some considerations about the allocation of finances in substance abusers Am J Drug Alcohol Abuse 38 2012 20 29
60. A. DeFulio, and K. Silverman Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: Post-intervention outcomes Addiction 106 2011 960 967